Therefore, when PD-1 on the surface of activated T cells binds to PD-L1 expressed by tumor cells, the activation, proliferation, survival, cytokine secretion, and cytotoxic activity of T cells are inhibited, resulting in impaired downstream anti-tumor immune responses and ultimately tumor cells immune escape (48). Here, PDCD1 is linked to neoplasm.